EL7.AI
StocksMediumUpdated•Originally published 31 March 2026•Updated 31 March 2026•
1 min read

BioHarvest Sciences Reports 37% Revenue Growth in 2025 as Losses Narrow

Key Facts

1BioHarvest recorded full-year 2025 revenue of $34.5 million, a 37% increase over the previous year.
2Financial results showed margin expansion and a narrowing of net losses.
3The company continues to invest in its product and contract manufacturing business segments.

BioHarvest Sciences Inc. (NASDAQ: BHST) reported full-year 2025 revenue of $34.5 million, marking a 37% increase over the previous year. In the fourth quarter, the company posted a loss of $0.10 per share, outperforming the Zacks Consensus Estimate of a $0.11 loss. This performance reflects a significant year-over-year improvement from the $0.17 loss per share recorded in the same period last year. While quarterly revenue figures lagged behind analyst expectations, the company's overall trajectory remains focused on narrowing net losses through improved operational efficiency. Strategic investments in core product segments and contract manufacturing continue to drive margin expansion. Management highlighted that these results underscore the company's progress toward achieving sustainable profitability in the biotech sector.